184 related articles for article (PubMed ID: 31684108)
1. Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer.
Huang YM; Cheng CH; Pan SL; Yang PM; Lin DY; Lee KH
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31684108
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 90 is involved in the regulation of HMGA2-driven growth and epithelial-to-mesenchymal transition of colorectal cancer cells.
Kao CY; Yang PM; Wu MH; Huang CC; Lee YC; Lee KH
PeerJ; 2016; 4():e1683. PubMed ID: 26893968
[TBL] [Abstract][Full Text] [Related]
3. siRNA-Mediated Silencing of HMGA2 Induces Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma.
Esmailzadeh S; Mansoori B; Mohammadi A; Shanehbandi D; Baradaran B
J Gastrointest Cancer; 2017 Jun; 48(2):156-163. PubMed ID: 27629422
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.
Chang HY; Ye SP; Pan SL; Kuo TT; Liu BC; Chen YL; Huang TC
Theranostics; 2017; 7(16):3889-3900. PubMed ID: 29109785
[TBL] [Abstract][Full Text] [Related]
5. Identification of the Effects of Aspirin and Sulindac Sulfide on the Inhibition of HMGA2-Mediated Oncogenic Capacities in Colorectal Cancer.
Ekanem TI; Tsai WL; Lin YH; Tan WQ; Chang HY; Huang TC; Chen HY; Lee KH
Molecules; 2020 Aug; 25(17):. PubMed ID: 32842685
[TBL] [Abstract][Full Text] [Related]
6. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53.
Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M
J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
[TBL] [Abstract][Full Text] [Related]
8. Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer.
Su YH; Tang WC; Cheng YW; Sia P; Huang CC; Lee YC; Jiang HY; Wu MH; Lai IL; Lee JW; Lee KH
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2261-72. PubMed ID: 25982393
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines.
Di Fazio P; Montalbano R; Neureiter D; Alinger B; Schmidt A; Merkel AL; Quint K; Ocker M
Exp Cell Res; 2012 Sep; 318(15):1832-43. PubMed ID: 22683924
[TBL] [Abstract][Full Text] [Related]
10. CPX Targeting DJ-1 Triggers ROS-induced Cell Death and Protective Autophagy in Colorectal Cancer.
Zhou J; Zhang L; Wang M; Zhou L; Feng X; Yu L; Lan J; Gao W; Zhang C; Bu Y; Huang C; Zhang H; Lei Y
Theranostics; 2019; 9(19):5577-5594. PubMed ID: 31534504
[No Abstract] [Full Text] [Related]
11. Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer.
Qi J; Zhou N; Li L; Mo S; Zhou Y; Deng Y; Chen T; Shan C; Chen Q; Lu B
Cell Death Dis; 2020 Jul; 11(7):582. PubMed ID: 32719342
[TBL] [Abstract][Full Text] [Related]
12. Increasing miR-150 and lowering HMGA2 inhibit proliferation and cycle progression of colon cancer in SW480 cells.
Zhang ZC; Wang GP; Yin LM; Li M; Wu LL
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6793-6800. PubMed ID: 30402842
[TBL] [Abstract][Full Text] [Related]
13. Oncological role of HMGA2 (Review).
Zhang S; Mo Q; Wang X
Int J Oncol; 2019 Oct; 55(4):775-788. PubMed ID: 31432151
[TBL] [Abstract][Full Text] [Related]
14. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
15. Effects of the antifungal agent ciclopirox in HPV-positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis.
Braun JA; Herrmann AL; Blase JI; Frensemeier K; Bulkescher J; Scheffner M; Galy B; Hoppe-Seyler K; Hoppe-Seyler F
Int J Cancer; 2020 Jan; 146(2):461-474. PubMed ID: 31603527
[TBL] [Abstract][Full Text] [Related]
16. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
[TBL] [Abstract][Full Text] [Related]
17. Ciclopirox targets cellular bioenergetics and activates ER stress to induce apoptosis in non-small cell lung cancer cells.
Lu J; Li Y; Gong S; Wang J; Lu X; Jin Q; Lu B; Chen Q
Cell Commun Signal; 2022 Mar; 20(1):37. PubMed ID: 35331268
[TBL] [Abstract][Full Text] [Related]
18. High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia.
Unachukwu U; Chada K; D'Armiento J
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365712
[TBL] [Abstract][Full Text] [Related]
19. Reposition of the Fungicide Ciclopirox for Cancer Treatment.
Huang Z; Huang S
Recent Pat Anticancer Drug Discov; 2021; 16(2):122-135. PubMed ID: 33573561
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
